Economic evaluations of interventions against influenza at workplaces: systematic review

Author:

Ofori S K1,Hung Y W2,Schwind J S1,Diallo K1,Babatunde D1,Nwaobi S O1,Hua X1,Sullivan K L1,Cowling B J3,Chowell G4,Fung I C H1ORCID

Affiliation:

1. Department of Biostatistics, Epidemiology and Environmental Health Sciences, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA, USA

2. Salient Advisory, Toronto, Ontario, Canada

3. WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region

4. Department of Population Health Sciences, School of Public Health, Georgia State University, Atlanta, GA, USA

Abstract

Abstract Background The burden of influenza is mostly felt by employees and employers because of increased absenteeism rates, loss of productivity and associated direct costs. Even though interventions against influenza among working adults are effective, patronage and compliance to these measures especially vaccination are low compared to other risk groups. Aims This study was aimed to assess evidence of economic evaluations of interventions against influenza virus infection among workers or in the workplace setting. Methods The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) reporting guideline for systematic reviews was followed. Three databases, PubMed, Web of Science and EconLit, were searched using keywords to identify relevant articles from inception till 25 October 2020. Original peer-reviewed papers that conducted economic evaluations of influenza interventions using cost–benefit, cost–effectiveness or cost–utility analysis methods focused on working-age adults or work settings were eligible for inclusion. Two independent teams of co-authors extracted and synthesized data from identified studies. Results Twenty-four articles were included: 21 were cost–benefit analyses and 3 examined cost–effectiveness analyses. Two papers also presented additional cost–utility analysis. Most of the studies were pharmaceutical interventions (n = 23) primarily focused on vaccination programs while one study was a non-pharmaceutical intervention examining the benefit of paid sick leave. All but two studies reported that interventions against influenza virus infection at the workplace were cost-saving and cost-effective regardless of the analytic approach. Conclusions Further cost–effectiveness research in non-pharmaceutical interventions against influenza in workplace settings is warranted. There is a need to develop standardized methods for reporting economic evaluation methods to ensure comparability and applicability of future research findings.

Publisher

Oxford University Press (OUP)

Subject

Public Health, Environmental and Occupational Health

Reference49 articles.

1. Vaccines against influenza WHO position paper—November 2012;World Health Organization (WHO).;J Weekly Epidemiol Rec,2012

2. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50–64 years;Nichol;Clin Infect Dis,2009

3. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population;Keech;Occup Med (Lond),1998

4. The effectiveness of vaccination against influenza in healthy, working adults;Nichol;N Engl J Med,1995

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3